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Abstract
Cancer has been a public health problem that has gained a lot of death. However, 
in spite of the advances in the diagnosis and treatment of cervical cancer, women 
follow the struggle versus this disease. Also, those patients suffer from limited 
efficacy and specificity, undesirable effects, drug resistance, and a high cost of 
treatments. Currently, several studies have demonstrated the efficiency of natural 
products, called bioactive compounds, against cervical cancer cell lines. Bioactive 
compounds, including polyphenols and phenolic acids or flavonoids, etc., have 
antioxidant and pro-oxidant properties. These compounds are efficacy and show 
high specificity because probably they act as anti-oxidant and pro-oxidant. The pro-
oxidant activity obstructs growth factors related to different signalling pathways 
that trigger cancer. Although, usually this kind of compounds helps for dispatching 
the apoptosis in cervical cancer cell. The aim of this chapter is reviewing how bioac-
tive compounds affect the signalling pathways.
Keywords: HeLa, cervical cancer, bioactive compounds, signalling pathway, 
polyphenols
1. Introduction
Cancer is a term for diseases in which abnormal cells divide without control and 
can invade nearby tissues. Typically, cells in healthy tissues only share if they receive 
growth stimulatory signals known as growth factors, those that together with the 
cytokines regulate the progression of the cell cycle [1]. The progressive transformation 
of normal cells into malignant derivatives implies the accumulation of some genetic 
changes, which can be carried in the germ line, by the development of somatic muta-
tion throughout the life of the individual, or by the incorporation of viruses, which 
eventually produce alterations in the cell cycle and DNA repair mechanisms [2, 3]. 
That triggers several oncogenic signalling pathways, leading to a series of drastic 
phenotypic and biochemical changes in the cell. These alterations refer to various 
areas, such as growth factor signalling, cell-cell adhesion, gene expression, motility or 
cell shape [4].
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Cancer rates continue to rise, particularly in the developed world, becoming 
one of the leading public health problems in many countries [5]. Many cancers are 
associated with longevity, and the possibility of their appearance increases as the 
life expectancy of individuals lengthens [6]. On the other hand, cancers of high 
prevalence are related to environmental factors and lifestyles, which involve a 
series of modifiable risk factors for their development such as smoking, drinking, 
diet, sun exposure and others [7]. Currently, many anticancer agents are avail-
able, including alkylating agents, antimetabolites, antitumor antibiotics, natural 
products and hormones [8]. However, treatments available for cervical cancer 
show low efficacy and specificity, undesirable effects, a high cost of treatment, 
relapsed among patients who had improved, drug resistance and a decreased 
quality of life [9–11].
The bioactive compounds present in plants, fruits and vegetables, are anti-
oxidant or stopping different signalling pathways including apoptosis and Wnt 
(Wingless/Integrates) [9–12]. Also, this kind of biocompounds has a selective 
cytotoxic effect, attacking only to the cancer cells [9, 10]. But, before its use, 
it is necessary to evaluate the activity of these therapies through in vitro anti-
proliferation assays, using cultures containing both tumour and non-tumour cells 
and different cell models [7]. Also, only few of these compounds have the potential 
to be therapeutic against cancer. This work describes the advance rise regarding 
the capacity of biocompounds to trigger or re-establish the antioxidant capacity or 
blocking oncogenes that participate in HeLa cancer cells.
2. Cervical cancer generalities
Cervical cancer (CC) is a principal cause of death in women in the whole world 
[9, 11, 13]. Prior reports indicated this cancer contributed with approximately 
500,000 new cases and produced between 270,000 and 300,000 deaths in 2015 
[9, 11, 13–15]. However, is clear that Hispanic women have a high incidence of cer-
vical cancer and a significant death rate than other women in the world [16, 17].  
The described above probably is due to the interaction between genetic factors 
of the population, geographic locations and environment exposures [18, 19]. In 
general, the susceptibility to the pathogens as human papillomaviruses (HPV), 
lifestyle and cultural factors and inadequate medical system contribute to the 
development of cervical cancer [17–19].
2.1 Cancer cervical and human papilloma virus (HPV)
Current information noticed that almost 100 serotypes of HPV exist. But, 2 
of these, 16 and 18 serotypes, are related to the development of cervical cancer in 
Latin women [14, 17]. During cervical carcinogenesis, a viral protein E6 seques-
ters to p53 protein. Also, another viral protein called E7 participates in the same 
process, sequestering Rb protein. In consequence, the arrest of both proteins p53 
and Rb induces deregulation in the cell cycle. However, possibly the HPV is not an 
exclusive aetiology agent that produces this disease. Further information noticed 
that sex steroid hormone participates in the early stages of cervical carcinogenesis 
[14]. Previous report evidenced the possible relationship between E7 viral and 
E2 (17β, also spelled oestradiol), but this is poorly understood [14]. Perhaps, our 
knowledge about the risk factors that derive from the developed cancer will be 
increasing but also is necessary to improve our awareness of the prevention and 
treatment of disease.
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2.2 Current therapies against cervical cancer
In this context, in Mexico 15% of women are detected with precancerous lesions 
of cervical cancer, and they could be potentially prevented. Currently, chemother-
apy, radiotherapy, hormonal therapy, biological therapy and surgery are the treat-
ments majority employed in the early stages of CC [10, 20, 21]. But, the treatments 
above mentioned often are associated with certain disadvantages, such as toxicity of 
chemical agent or drug resistance [22]. For example, cisplatin in combination with 
bevacizumab can increase the expectations of survival, but they are scarce to the pop-
ulation. In another case, paclitaxel is a chemotherapeutic agent used against ovarian 
carcinoma, but there is evidence of the resistance for this agent [11]. Also, the use of 
chemotherapy represents other drawbacks, the undesirable effects, the high cost of 
treatment and recurrence among patients who had improved [10, 20]. All of these 
adverse effects are due to the lack of a specific target cancer cell, because chemo-
therapeutics do not have a cancer-specific receptor, protein or DNA [20]. Another 
limit, in Mexico, there is one radiotherapy machine available for 2 million Mexican. 
But, reducing the doses of the chemical agent or employing natural compounds can 
overcome this significant barrier that exists to eliminate CC [11]. Natural or bioactive 
compounds are used against multiple illnesses including rheumatic, anthelmintic, 
diuretic, hypoglycaemia and cancer [23].
2.3 Relationship between ROS and cervical cancer
The diseases above mentioned, including CC, could produce free radicals that 
induce damage to the cells, tissues and organs [12]. However, the proper function of 
cells depends on the mitochondria’s ability to regulate metabolic processes and produce 
molecules, including free radicals as reactive oxygen species (ROS) [11, 24, 25]. ROS 
controls both physiological and pathological process related to cell proliferation, invasion 
cell, and tumour hypoxia and drug resistance [11, 12, 26, 27]. Also, in the cell, a defence 
system against ROS includes several enzymes such as superoxide dismutase, catalase, 
glutathione peroxidase, glutathione reductase and glutathione S-transferase [28].  
However, when the cellular antioxidant systems are damaged, antioxidants are insuf-
ficient to neutralise ROS, and then oxidative stress occurs [27, 29]. Moreover, in a patho-
logical process, ROS are responsible for damaging proteins, lipids and nucleic acids [29, 
30]. Nonetheless, bioactive compounds are strongly linked to the radical scavenging 
capacity and protect the cell against oxidative DNA damage [12, 25, 31].
2.4 Alternative therapy among cervical cancer
The plants, fruits and vegetable contain large amounts of bioactive compounds 
that act as antioxidant, and they can be used with therapeutic purpose [27, 32, 33]. 
Among antioxidants, different subclasses are described, (a) flavonoids, (b) phenolic 
acids and polyphenols, (c) stilbenoids, (d) catechins and (e) tannins, and they are 
abundant and available in natural products previously mentioned [20, 31, 34]. Other 
compounds related with their oxidant capacity and ROS productions are listed in 
Table 1. The antioxidants that are most well-known, curcumin, resveratrol and 
gallic acid, have activity against cancer cell line in vitro [15, 24, 28, 35]. For example, 
galangin is a flavonoid with various biological effects in different cancer cells [25]. 
Also, the green tea has cancer-preventive effects due to containing catechins known as 
EGCG (−)-epicatechin-3-gallate, (−)-epigallocatechin and (−)-epicatechin. Also, CTS 
extract possesses chlorogenic acid, (+)-catechin, caffeic acid, phloretic acid, veratric 
acid, hesperidin, quercetin and naringenin. Additionally, fucoidan is a major bioactive 
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compound in Sargassum polycystum and demonstrated anti-proliferation, antitumor 
and anticancer properties [13]. Moreover, pterostilbene can be found in berries and 
grapes and showed therapeutic effects in a variety of cancer types [36]. Other biocom-
pounds such as triptolide, celastrol and tripchlorolide were isolated from Tripterygium 
wilfordii; these compounds are immunosuppressive and anticancer [37]. Gallic acid 
is a natural phenolic compound with the potential to act against different cancers or 
viruses [38]. Further information, extracts from Annona muricata leaves were shown 
to have the capacity to induce apoptosis in HeLa cells, suggesting that the extracts have 
the potential to be used as a treatment against virus-induced cancer cells [39]. Also, 
this compound can be used in combination with a chemotherapeutic agent to increase 
the efficiency of chemotherapy [11].
Also, the genus Annona has been shown to have promising compounds, called 
Annonaceous acetogenins (AGEs), that can be utilised in the treatment of cancer 
because they induce cell cytotoxicity by inhibiting the mitochondrial complex I,  
and their capacity of acetogenins to inhibit NADH oxidase was also shown to be 
important for their antitumour function [40, 41]. However, the biological activi-
ties of the compounds obtained from Annona species are diverse. For example, 
the crude extract of A. crassiflora significantly alters cell viability of cervical can-
cer cell lines as well as proliferation and migration and induces cell death [42]. 
Many studies have described, or continuous screening the anticancer bioactive 
compounds, and explained the potential of plants against illness [25]. Though, 
Compound Anti-carcinogenic effects
Terpenes and steroids Inhibit cancer cell proliferation and metastasis; cell cycle arrest, apoptosis, 
anti-angiogenesis, anti multidrug resistance
Alkaloids Target DNA replication or protein synthesis, resulting in apoptosis of the 
neoplastic cells
Phenolic compounds
Chalcones Anticancer, anti-inflammatory, antioxidant; cytotoxic activities through 
multiple mechanisms which include cell cycle disruption, angiogenesis 
inhibition, tubulin polymerization inhibition, apoptosis induction and blockade 
of nuclear factor-kappa B (NF-B) signalling pathway
Coumarins Antioxidants and anti-inflammatory; anti-proliferative activity may be due to 
inhibition of CDK2 activity
Flavonoids Antioxidant and cytotoxic effect, cell growth and proliferation inhibition; 
modulate the metabolism of carcinogen, inhibition of multidrug resistance, 
anti-angiogenesis effect, induce apoptosis and cell cycle arrest
Hydroxybenzoic acids Antioxidant capacity; inhibit cell proliferation and cell cycle progression; 
metalloproteinase inhibition
Hydroxycinammic acids Anti-proliferative effect; suppressive effects of signalling pathways 
that are related to NF-κB, ERK, protein kinase C, calcium signalling, 
phosphatidylinositol 3-kinase (PI3K) and nuclear transcription activity
Lignins Antioxidant and cytotoxic effect
Lignans Cytotoxic potential; angiogenesis and metastasis inhibition induces apoptosis
Stilbenes Antioxidant activity; inhibition of cancer cell proliferation, induces apoptosis 
and reduces angiogenesis
Xanthones Antioxidant and pro-apoptotic effect; anti-proliferative, cell-cycle arrest
Antioxidant properties can be risen with phenolic compounds described here. However, possible signalling pathways, 
apoptotic or inflammation, can be affected by this kind of compounds.
Table 1. 
List of phenolic compounds. Antioxidant properties can be risen with phenolic compounds described here. 
However, possible signalling pathways, apoptotic or inflammation, can be affected by this kind of compounds.
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the success of the prevention or treatment depends on the quality and quantity 
of bioactive compounds. But, the biological effects and mechanisms of action of 
flavonoids, phenolic acids, stilbenoids and tannins have been studied lightly.
2.5 Antioxidant and ROS cancer prevention
Antioxidant capacities describe the biological mechanism of bioactive compounds 
and how consequence prevents the oxidative stress in normal cell [11, 31, 35, 43]. But 
these compounds also can act as pro-oxidant agent and increase the ROS production 
in cancer cell [11, 31, 35, 43]. However, Gu et al. mentioned that those compounds are 
antioxidants in lower concentration and can be a pro-oxidant at a high level [31]. Also, 
the intake of polyphenols and phenolic compounds has multiple protective functions 
against inflammation and tumorigenesis. However, the success of the prevention and 
treatment also depends on the quality and quantity of bioactive compounds. But, 
more critical is the fact that the consumption and bioavailability of polyphenols are 
insufficiently studied to determine the efficacy for disease prevention or disease treat-
ment [15, 35]. From this, derive the relationship among bioactive compounds and the 
induction of apoptosis, anti-proliferation, antimetastasis and anti-angiogenesis [12]. 
Further information notices the interaction of the phenolic compound is involved 
with receptor or enzymes in signal transduction [31]. This interaction may downregu-
late or upregulate essential proteins in signalling pathways that control the biological 
process [35].
2.6 Signalling pathways blocked by polyphenols
In addition to the antioxidant effects above mentioned, these bioactive com-
pounds can induce two phases during ROS activation. Phase I starts when poly-
phenols inhibit cytochrome P450 (CYPs) including CYP1A1 and CYP1B1, and 
the increase and excretion of polar metabolites and prevention of the formation 
of DNA adducts remark phase II [35, 44]. But, pro-oxidant activities mediated 
by polyphenols and phenolic compounds increase the ROS production. Lin et al. 
reported that resveratrol induced apoptosis in HeLa cell line [15]. The extract of 
Cudrania tricuspidata stem (CTS) on cell viability was investigated in HPV-positive 
cervical cancer cells. CTS induced apoptosis by downregulating the E6 and E7 viral 
oncogenes. Also, the mRNA expression levels of extrinsic pathway molecules such 
as Fas, death receptor 5 (DR5) and TNF-related apoptosis-inducing ligand (TRAIL) 
were increased by CTS. CTS induced apoptosis by activating the extrinsic pathway 
in SiHa cervical cancer cells. Chlorogenic acid has been reported to have anticancer, 
antioxidant and antidiabetic effects. Also, galangin increased ROS, which induced the 
activation of cell death via various mechanisms including apoptosis or arrest of cell 
cycle [15, 20, 25]. Bruges reported that pyrogallol induced mitochondrial apoptotic 
response. Mitochondrial pathway probably begins with the activation of BH3-only 
proteins. This protein causes the production of BAK1 and BAX, which promote a 
membrane permeabilisation. Last, in cytoplasm increasing cytochrome C level, 
this allows apoptosome formation and caspase-9 activations. In extrinsic apoptosis 
pathway, binding of the cell death ligands and cell death receptors activates caspase-8 
and caspase-3 (Figure 1) [35, 45]. Similarly, Terminalia sericea enabled caspases-7 
and -8 and poly (ADP-ribose) polymerase (PARP) in HeLa cancer cell line [31]. Also, 
pyrogallol induces superoxide anion, and this generates activation of caspase-3 and 
phosphatidylserine [45]. Silva et al. mentioned that the hexane partition derived from 
the crude extract presented cytotoxic effect in SiHa cells and initiates cell responses, 
such as DNA damage (H2AX activity), apoptosis via intrinsic pathway (cleavage 
of caspase-9, caspase-3, poly (ADP-ribose) polymerase (PARP) and mitochondrial 
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membrane depolarization) and decreased p21 expression by ubiquitin proteasome 
pathway [42]. Fusi et al. reported that the antioxidant activity of resveratrol, cat-
echin, curcumin, etc. increases sirtuin 1 (SIRT1) expression and monophosphate-
activated protein kinase (AMPK) activation in HeLa cell line [27, 44]. Prior reports 
indicated AMPK is an enzyme that inhibits anabolic process and increases catabolic 
activity. Perhaps, the relationship between SIRT1 and AMPK may protect against 
oxidative stress [27, 44]. On the other hand, pro-oxidant activities induced by poly-
phenols generate ROS and produce [1] cell cycle arrest, and [2] induction of apoptosis 
and DNA fragmentation. In HeLa cells, autophagy-signalling pathways are modu-
lated by polyphenols, i.e. resveratrol, curcumin and genistein, and act on epidermal 
growth factor kinase B (EFGR)/AMPK, and this inhibits the mammalian target of 
rapamycin (mTORC1) via TSC1/2. Also, these three polyphenols inhibit nuclear 
factor kappa-light-enhancer of activated B cells (NF-κB), and these compounds plus 
quercetin stop phosphatidilinositide 3-kinases/protein kinase B (PI3K/Akt), and 
last, rottlerin breaks PKC5 [35, 44]. Last, safflower polysaccharide (SPS) is a major 
active component of Carthamus tinctorius. SPS inhibited proliferation and increased 
apoptosis of HeLa cells through downregulation of the phosphatidylinositol-3-kinase/
AKT pathway [46].
3. Conclusions
The potential disadvantage that represents the strategies against cervical cancer 
or other cancers is the resistance, high cost, secondary effects and disposal of phar-
maceuticals. However, extracts of plants, including phenolic acid and polyphenolic, 
flavonoids, etc., have gained remarkable interest such as new treatment or strategies 
versus cervical cancer. The antioxidant properties of plants were demonstrated with 
multiple investigations, some of which are pointed out in this chapter, especially 
for its antioxidant properties, influence on cellular apoptosis, ROS increase, etc. 
Figure 1. 
Effect of biocompounds in cellular processes. In the figure, it is observed that at low concentrations, 
biocompounds (left) can exert an antioxidant effect, whereby it acts by reducing reactive oxygen species. 
However, at high concentrations (right), biocompounds have pro-oxidant effects, which can affect both normal 
and carcinogenic cells and result in alteration of key pathways for homeostasis of the cell, causing cell cycle 
arrest and stop cell proliferation, damage to DNA and apoptosis, among others, cellular process.
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Currently the efforts to discover new anticancer agents continue, and it is possible 
that plants containing compounds still unknown and that compounds could modu-
late the pathways that government cancer. Also, the signalling pathways regulated 
by these compounds have been superficially studied. Unfortunately, these foods are 
not always available to all people, and in the case of those who have them within 
reach, they do not consume them. Also, it is important that people change their 
hygienic dietary habits and improve the quality of their immune system and the 
level of cellular oxidative stress does not increase the risk for development of cancer.
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